That's a good (and complex) question, not sure there's enough data to answer at this stage.
But as clarified above, CYP tech produces MSC, which may later lead to MPC.
Keep in mind also, that CYP uses a process that combines iPSC (licensed from Cellular Dynamics) with MCA cells to produce the MSC.
The tech is new. So one safety question CYP will need to answer is the tumerogenicity of the resultant MSC, because iPSC have been shown to be aggressive in tumour formation.
MSC V MPC, page-10
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $48.78M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 145786 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |